Xcellerant Ventures
  • Portfolio
  • Team
  • About
  • Invest
  • News
  • Jetstream
  • Contact
Select Page
Wave Health Study Earns Selective Spot for Poster Presentation at 2024 European Urological Cancer Conference

Wave Health Study Earns Selective Spot for Poster Presentation at 2024 European Urological Cancer Conference

by Tiffany Youtchoko | Nov 11, 2024 | Portfolio Company News

Lisbon, Portugal and El Segundo, CA – November 11 “PRO-WAVE1: Monitoring patient reported outcomes (PROs) in prostate cancer through Wave Health, a novel ePRO health platform” presents further findings on November 9, 2024. Lisbon, Portugal and El Segundo, CA...
Wave Health Named a 2024 ASCO Breakthrough Abstract Award Winner

Wave Health Named a 2024 ASCO Breakthrough Abstract Award Winner

by Tiffany Youtchoko | Jul 17, 2024 | Portfolio Company News

Origionally posted on TTI’s website: https://tti.care/2024-asco-breakthrough-abstract-award-winner/   Recognized by Conquer Cancer®, the ASCO® Foundation, and the 2024 ASCO® Breakthrough Program Committee, Prestigious Award Recognizes Top Scoring Study...
CRISPR 2.0: Kinder, Gentler, More Powerful Gene Editing

CRISPR 2.0: Kinder, Gentler, More Powerful Gene Editing

by Tiffany Youtchoko | Jun 1, 2024 | Portfolio Company News

Origionally posted on Genetic Engineering and Biotechnology News: https://www.genengnews.com/topics/genome-editing/crispr-2-0-kinder-gentler-more-powerful-gene-editing/   Scientists have worked tirelessly to develop ever more precise and efficient CRISPR-Cas...
Using Data to Advance Health Equity

Using Data to Advance Health Equity

by Tiffany Youtchoko | May 15, 2024 | Portfolio Company News

Origionally posted on In Full Health: https://infullhealth.org/blog/using-data-advance-health-equity/   Alan Roga, MD, FACEP, is a healthcare technology entrepreneur and emergency medicine physician. He has over 25 years of experience in healthcare, including his...
Novel Study to Assess Wave Health For Stem Cell Transplant Patients Delivers Promising Results and Valuable Real-World Data

Novel Study to Assess Wave Health For Stem Cell Transplant Patients Delivers Promising Results and Valuable Real-World Data

by Tiffany Youtchoko | Apr 26, 2024 | Portfolio Company News

Origionally posted on TTI’s website: https://tti.care/wilmot-cancer-institute-tti-study-presented-ons/   Selected for oral abstract presentation at the 2024 Oncology Nursing Society (ONS) Congress, promoting excellence in oncology nursing and the...

Recent Posts

  • Democratizing health care: There’s an app for that
  • Nanodropper® Now Operating as Mu Medical™, Planned Expansion of Precision Eyecare Platform with Bedo Solutions and Viseon Labs
  • DeepLook Medical Expands Precision Imaging Capabilities Through Strategic Partnerships and Expert Advisors, Integrating Innovative Solutions into Widely Used Platforms to Deliver Critical Insights at
  • DeepLook Medical and NHS Oxford University UK announce new study
  • Scottsdale’s Xcellerant Ventures Launches Jetstream Venture Fund, Expanding Access to VC-Style Investing

Recent Comments

No comments to show.
  • Portfolio
  • Team
  • About
  • Invest
  • News
  • Contact
  • Privacy Policy
© Xcellerant Ventures 2023